Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor

Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor

US Patent 9732139 · Granted Aug 15, 2017

Estimated economic value: $2,780,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HDAC6 inhibitors for treatment of metabolic disease and HFpEF2025
Thailanstatin analogs2023
VEGF/DLL4 binding agents and uses thereof2022
Combination therapy for treatment of disease2021
Combination therapy for treatment of disease2021
Thailanstatin analogs2020
Use of neutrophil elastase inhibitors in liver disease2020
VEGF/DLL4 binding agents and uses thereof2020
TIGIT-binding agents and uses thereof2020
Thailanstatin analogs2019
Method of treating cancer by administering tumor necrosis factor receptor ligand2019
Tight-binding agents and uses thereof2018